Exact Sciences Raises $125M in Series D

Exact Sciences has successfully raised $125M in a Series D at a $1.5B valuation led by Casdin Capital, Fidelity.

Company Overview

Exact Sciences is a Biotech company headquartered in Madison, WI, founded in 1995 with 5000+ employees.

Cancer screening and diagnostics

Fundraising Details

Amount Raised: $125M
Round Type: Series D
Valuation: $1.5B
Date: 2015-02-25
Investors: Casdin Capital, Fidelity

About Exact Sciences

Cancer screening and diagnostics The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Madison, WI
Founded: 1995
Team Size: 5000+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Exact Sciences's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Exact Sciences's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $1.5B valuation marks an important milestone for Exact Sciences, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Exact Sciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2015-02-25. For more information about Exact Sciences, visit their headquarters at Madison, WI.

Exact Sciences